8Katja Ott,Andreas Sendler,Karen Becker,Hans-Joachim Dittler,Hermann Helmberger,Raimonde Busch,Christian Kollmannsberger,J. Rüdiger Siewert,Ulrich Fink. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study[J] 2003,Gastric Cancer(3):159～167
9Y. Adachi,N. Shiraishi,K. Ikebe,M. Aramaki,T. Bandoh,S. Kitano. Evaluation of the cost for laparoscopic-assisted Billroth I gastrectomy[J] 2001,Surgical Endoscopy(9):932～936
2Kamangar F,Dores GM,Anderson WF. Patterns of cancer incidence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world[J].Journal of Clinical Oncology,2006,(14):2137-2150.
3Chu QS,Hammond LA,Schwartz G. Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies[J].Clinical Cancer Research,2004,(15):4913-4921.
4Huang J,Cao Y,Wu L. S-1-based therapy versus 5-FU-based therapy in advanced gastric cancer:a meta-analysis[J].MEDICAL ONCOLOGY,2011,(04):1004-1011.
5Koizumi W,Narahara H,Hara T. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer(SPIRITS trial):a phase III trial[J].The Lancet Oncology,2008,(03):215-221.
6Montagnani F,Turrisi G,Marinozzi C. Effectiveness and safety of oxaliplatin compared to cisplatin for advanced,unresectable gastric cancer:a systematic review and meta-analysis[J].GASTRIC CANCER,2011,(01):50-55.
7Oh SY,Kwon HC,Jeong SH. A phase II study of S-1 and oxaliplatin(SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer[J].Investigational New Drugs,2012,(01):350-356.
8Park I,Lee JL,Ryu MH. Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer[J].Cancer Chemotherapy and Pharmacology,2010,(03):473-480.
9Koizumi W,Kim YH,Fujii M. Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer:a randomized study(START)[J].Journal of Cancer Research and Clinical Oncology,2014,(02):319-328.
10Yoshida K,Ninomiya M,Takakura N. Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer[J].Clinical Cancer Research,2006,(11):3402-3407.
